TARA KARMO: Open Payments
NPI 1639413891 · YPSILANTI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 10 payments from 5 companies in 2025. Trend: 2023 $783 · 2024 $694 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Ardelyx, Inc. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
Products named: TREMFYA, DUPIXENT, ENTYVIO, IBSRELA, XIFAXAN.
Industry payments across MI — which companies pay providers there.
